{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:49:23Z","timestamp":1792144163202,"version":"4.4.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2743434","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:30:02Z","timestamp":1792143002000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer cells"],"prefix":"10.1080","volume":"41","author":[{"given":"Yi-Wen","family":"Wu","sequence":"first","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lin","family":"Yang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Fang-Chin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hsuan","family":"Yeh","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Jiun","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ying","family":"Sung","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Chun","family":"Chu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Eight","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chung","family":"Yen","sequence":"additional","affiliation":[{"name":"Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong (Shenzhen)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Hua","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Division of Translational Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sing-Han","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Digital Biology, Graphen Drugomics Inc.","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ying","family":"Chu","sequence":"additional","affiliation":[{"name":"CRISPR Gene Targeting Core, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"TMU Research Center of Cancer Translational Medicine, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Chien","family":"Yang","sequence":"additional","affiliation":[{"name":"Department and Graduate Institute of Pharmacology, National Taiwan University College of Medicine","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Cheng","family":"Hsu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"TMU Research Center of Cancer Translational Medicine, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Ph.D. Program in Innovative Medical Technology Research and Development Industry, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Cancer Center, Wan Fang Hospital, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiow-Lin","family":"Pan","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"TMU Research Center of Cancer Translational Medicine, Taipei Medical University","place":["Taipei, Taiwan"]},{"name":"Ph.D. Program in Innovative Medical Technology Research and Development Industry, College of Medical Science and Technology, Taipei Medical University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"3","key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in pancreatic cancer","volume":"160","author":"Huang J","year":"2021","unstructured":"Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, Ng K, Chong C, Zheng ZJ, Wong MCS. Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology. 2021;160(3):744\u2013754.","journal-title":"Gastroenterology"},{"issue":"1","key":"e_1_3_3_3_1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention","volume":"164","author":"Stoffel EM","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164(5):752\u2013765.","journal-title":"Gastroenterology"},{"issue":"11","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"clinicalguidelines@esmo.org, Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy T","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, Hackert T, Golan T, Prager G, Haustermans K, and E.G.C.E.a, et al. clinicalguidelines@esmo.org, Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987\u20131002.","journal-title":"Ann Oncol"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"1002299","DOI":"10.37349\/etat.2025.1002299","article-title":"Pancreatic cancer: failures and hopes \u2013 a review of new promising treatment approaches","volume":"6","author":"Cereda V","year":"2025","unstructured":"Cereda V, D\u2019Andrea MR. Pancreatic cancer: failures and hopes \u2013 a review of new promising treatment approaches. Explor Target Antitumor Ther. 2025;6:1002299.","journal-title":"Explor Target Antitumor Ther"},{"issue":"1","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12896-025-01033-w","article-title":"In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating pancreatic cancer","volume":"25","author":"Kantarci-Carsibasi N","year":"2025","unstructured":"Kantarci-Carsibasi N, Girgin M, Fidan ND, Bal T, Tarbiat S. In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating pancreatic cancer. BMC Biotechnol. 2025;25(1):103.","journal-title":"BMC Biotechnol"},{"issue":"21","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1158\/1078-0432.CCR-08-0381","article-title":"Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma","volume":"14","author":"Liang JJ","year":"2008","unstructured":"Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res. 2008;14(21):7043\u20137049.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13046-018-0807-2","article-title":"Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4","volume":"37","author":"Fu Y","year":"2018","unstructured":"Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. J Exp Clin Cancer Res. 2018;37(1):130.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"2166039","DOI":"10.1080\/14756366.2023.2166039","article-title":"In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer","volume":"38","author":"Chang CD","year":"2023","unstructured":"Chang CD, Chao MW, Lee HY, Liu YT, Tu HJ, Lien ST, Lin TE, Sung TY, Yen SC, Huang SH, et al. In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. J Enzyme Inhib Med Chem. 2023;38(1):2166039.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"43","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1038\/s41388-021-02007-w","article-title":"MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3","volume":"40","author":"Singh SK","year":"2021","unstructured":"Singh SK, Kumar S, Viswakarma N, Principe DR, Das S, Sondarva G, Nair RS, Srivastava P, Sinha SC, Grippo PJ, et al. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3. Oncogene. 2021;40(43):6153\u20136165.","journal-title":"Oncogene"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"1162835","DOI":"10.3389\/fonc.2023.1162835","article-title":"MAP4K4 and cancer: ready for the main stage?","volume":"13","author":"Gonz\u00e1lez-Montero J","year":"2023","unstructured":"Gonz\u00e1lez-Montero J, Rojas CI, Burotto M. MAP4K4 and cancer: ready for the main stage? Front Oncol. 2023;13:1162835.","journal-title":"Front Oncol"},{"issue":"9","key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1369\/0022155415590829","article-title":"Silencing SOX2 expression by RNA interference inhibits proliferation, invasion and metastasis, and induces apoptosis through MAP4K4\/JNK signaling pathway in human laryngeal cancer TU212 cells","volume":"63","author":"Yang N","year":"2015","unstructured":"Yang N, Wang Y, Hui L, Li X, Jiang X. Silencing SOX2 expression by RNA interference inhibits proliferation, invasion and metastasis, and induces apoptosis through MAP4K4\/JNK signaling pathway in human laryngeal cancer TU212 cells. J Histochem Cytochem. 2015;63(9):721\u2013733.","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1128\/MCB.23.6.2068-2082.2003","article-title":"The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion","volume":"23","author":"Wright JH","year":"2003","unstructured":"Wright JH, Wang X, Manning G, LaMere BJ, Le P, Zhu S, Khatry D, Flanagan PM, Buckley SD, Whyte DB, et al. The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion. Mol Cell Biol. 2003;23(6):2068\u20132082.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/mmr.2015.4510","article-title":"Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells","volume":"13","author":"Liu YF","year":"2016","unstructured":"Liu YF, Qu GQ, Lu YM, Kong WM, Liu Y, Chen WX, Liao XH. Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells. Mol Med Rep. 2016;13(1):41\u201348.","journal-title":"Mol Med Rep"},{"issue":"11","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1535-7163.MCT-13-0296","article-title":"miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4","volume":"12","author":"Zhao G","year":"2013","unstructured":"Zhao G, Wang B, Liu Y, Zhang JG, Deng SC, Qin Q, Tian K, Li X, Zhu S, Niu Y, et al. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol Cancer Ther. 2013;12(11):2569\u20132580.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082272","article-title":"Molecular insights of MAP4K4 signaling in inflammatory and malignant diseases","volume":"15","author":"Singh SK","year":"2023","unstructured":"Singh SK, Roy R, Kumar S, Srivastava P, Jha S, Rana B, Rana A. Molecular insights of MAP4K4 signaling in inflammatory and malignant diseases. Cancers (Basel). 2023;15(8):2272.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1021\/acsmedchemlett.5b00174","article-title":"Structure-based design of GNE-495, a potent and selective MAP4K4 inhibitor with efficacy in retinal angiogenesis","volume":"6","author":"Ndubaku CO","year":"2015","unstructured":"Ndubaku CO, Crawford TD, Chen H, Boggs JW, Drobnick J, Harris SF, Jesudason R, McNamara E, Nonomiya J, Sambrone A, et al. Structure-based design of GNE-495, a potent and selective MAP4K4 inhibitor with efficacy in retinal angiogenesis. ACS Med Chem Lett. 2015;6(8):913\u2013918.","journal-title":"ACS Med Chem Lett"},{"issue":"7","key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1021\/acs.jmedchem.8b00152","article-title":"2-Aminopyridine-based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) inhibitors: assessment of mechanism-based safety","volume":"61","author":"Dow RL","year":"2018","unstructured":"Dow RL, Ammirati M, Bagley SW, Bhattacharya SK, Buckbinder L, Cortes C, El-Kattan AF, Ford K, Freeman GB, Guimar\u00e3es CRW, et al. 2-Aminopyridine-based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) inhibitors: assessment of mechanism-based safety. J Med Chem. 2018;61(7):3114\u20133125.","journal-title":"J Med Chem"},{"issue":"18","key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1016\/j.bmcl.2014.07.071","article-title":"Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors","volume":"24","author":"Wang L","year":"2014","unstructured":"Wang L, Stanley M, Boggs JW, Crawford TD, Bravo BJ, Giannetti AM, Harris SF, Magnuson SR, Nonomiya J, Schmidt S, et al. Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. Bioorg Med Chem Lett. 2014;24(18):4546\u20134552.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1038\/ncomms9357","article-title":"MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway","volume":"6","author":"Meng Z","year":"2015","unstructured":"Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, Park HW, Mo J-S, Lu W, Lu S, et al. MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway. Nat Commun. 2015;6(1):8357.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.274027.115","article-title":"Mechanisms of Hippo pathway regulation","volume":"30","author":"Meng Z","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30(1):1\u201317.","journal-title":"Genes Dev"},{"issue":"21","key":"e_1_3_3_23_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213719","article-title":"The immunomodulatory effect of different FLT3 inhibitors on dendritic cells","volume":"16","author":"Schlaweck S","year":"2024","unstructured":"Schlaweck S, Radcke A, Kampmann S, Becker BV, Brossart P, Heine A. The immunomodulatory effect of different FLT3 inhibitors on dendritic cells. Cancers (Basel). 2024;16(21):3719.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1021\/jm500155b","article-title":"Discovery of selective 4-amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization","volume":"57","author":"Crawford TD","year":"2014","unstructured":"Crawford TD, Ndubaku CO, Chen H, Boggs JW, Bravo BJ, Delatorre K, Giannetti AM, Gould SE, Harris SF, Magnuson SR, et al. Discovery of selective 4-amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization. J Med Chem. 2014;57(8):3484\u20133493.","journal-title":"J Med Chem"},{"key":"e_1_3_3_25_1","unstructured":"LeadIT B. Available from: http:\/\/www.biosolveit.de\/LeadIT."},{"key":"e_1_3_3_26_1","volume-title":"Pipeline pilot","author":"Biovia DS.","year":"2021","unstructured":"Biovia DS. Pipeline pilot. Dassault Syst\u00e8mes; 2021."},{"issue":"1","key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa M","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucl Acid Res. 2000;28(1):27\u201330.","journal-title":"Nucl Acid Res"},{"issue":"4","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040589","article-title":"Heme Oxygenase-1 signaling and redox homeostasis in physiopathological conditions","volume":"11","author":"Consoli V","year":"2021","unstructured":"Consoli V, Sorrenti V, Grosso S, Vanella L. Heme Oxygenase-1 signaling and redox homeostasis in physiopathological conditions. Biomolecules. 2021;11(4):589.","journal-title":"Biomolecules"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbior.2016.05.001","article-title":"Gene regulation in the immediate-early response process","volume":"62","author":"Bahrami S","year":"2016","unstructured":"Bahrami S, Drabl\u00f8s F. Gene regulation in the immediate-early response process. Adv Biol Regul. 2016;62:37\u201349.","journal-title":"Adv Biol Regul"},{"issue":"1","key":"e_1_3_3_30_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-026-02987-2","article-title":"Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications","volume":"12","author":"Xiao Y","year":"2026","unstructured":"Xiao Y, Wang W, Wang G, Liu Y, Gong J. Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications. Cell Death Discov. 2026;12(1):117.","journal-title":"Cell Death Discov"},{"issue":"22","key":"e_1_3_3_31_1","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.7150\/jca.64031","article-title":"Keratin 80 regulated by miR-206\/ETS1 promotes tumor progression via the MEK\/ERK pathway in ovarian cancer","volume":"12","author":"Liu O","year":"2021","unstructured":"Liu O, Wang C, Wang S, Hu Y, Gou R, Dong H, Li S, Li X, Lin B. Keratin 80 regulated by miR-206\/ETS1 promotes tumor progression via the MEK\/ERK pathway in ovarian cancer. J Cancer. 2021;12(22):6835\u20136850.","journal-title":"J Cancer"},{"issue":"48","key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1038\/onc.2012.6","article-title":"Targeting tumor cell metabolism with statins","volume":"31","author":"Clendening JW","year":"2012","unstructured":"Clendening JW, Penn LZ. Targeting tumor cell metabolism with statins. Oncogene. 2012;31(48):4967\u20134978.","journal-title":"Oncogene"},{"issue":"2","key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymeth.2014.05.009","article-title":"Intracellular drug concentration and disposition \u2013 the missing link?","volume":"68","author":"Hann MM","year":"2014","unstructured":"Hann MM, Simpson GL. Intracellular drug concentration and disposition \u2013 the missing link? Methods. 2014;68(2):283\u2013285.","journal-title":"Methods"},{"issue":"30","key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"E6231","DOI":"10.1073\/pnas.1701848114","article-title":"Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery","volume":"114","author":"Mateus A","year":"2017","unstructured":"Mateus A, Gordon LJ, Wayne GJ, Almqvist H, Axelsson H, Seashore-Ludlow B, Treyer A, Matsson P, Lundback T, West A, et al. Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery. Proc Natl Acad Sci USA. 2017;114(30):E6231\u2013E6239.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chembiol.2017.10.010","article-title":"Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement","volume":"25","author":"Vasta JD","year":"2018","unstructured":"Vasta JD, Corona CR, Wilkinson J, Zimprich CA, Hartnett JR, Ingold MR, Zimmerman K, Machleidt T, Kirkland TA, Huwiler KG, et al. Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement. Cell Chem Biol. 2018;25(2):206\u2013214.e11. e211.","journal-title":"Cell Chem Biol"},{"issue":"12","key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.chembiol.2019.10.005","article-title":"Development of MAP4 kinase inhibitors as motor neuron-protecting agents","volume":"26","author":"Bos PH","year":"2019","unstructured":"Bos PH, Lowry ER, Costa J, Thams S, Garcia-Diaz A, Zask A, Wichterle H, Stockwell BR. Development of MAP4 kinase inhibitors as motor neuron-protecting agents. Cell Chem Biol. 2019;26(12):1703\u20131715.e37. e1737.","journal-title":"Cell Chem Biol"},{"issue":"4","key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.stem.2019.01.013","article-title":"MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo","volume":"24","author":"Fiedler LR","year":"2019","unstructured":"Fiedler LR, Chapman K, Xie M, Maifoshie E, Jenkins M, Golforoush PA, Bellahcene M, Noseda M, Faust D, Jarvis A, et al. MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo. Cell Stem Cell. 2019;24(4):579\u2013591.e12. e512.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"W469","DOI":"10.1093\/nar\/gkae254","article-title":"Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction","volume":"52","author":"Myung Y","year":"2024","unstructured":"Myung Y, de S\u00e1 AGC, Ascher DB. Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucl Acids Res. 2024;52(W1):W469\u2013W475.","journal-title":"Nucl Acids Res"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2743434","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14756366.2026.2743434","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2743434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:30:08Z","timestamp":1792143008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2743434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2743434"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2743434","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2743434"}}